Tyrosine Kinase Inhibitors Outperform Immune Checkpoint Inhibitors in Bone-Predominant Metastatic Renal Cell Carcinoma: A Multicenter Real-World Analysis. - Meng L; Psutka SP; Gheeya J; Li M; Noonavath M; Orcutt D; Gross E; Collier KA; Mortazavi A; Folefac E; Monk P; Yang Y (Journal of Cancer, 2025)